OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Oxurion NVApril 30, 2021 GMT
Leuven, BE, Boston, MA, US – April 30st, 2021 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies with a clinical stage portfolio in retinal vascular disorders. Oxurion NV is announcing the presentation of novel scientific data at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting which is held on May 1-7, 2021.
Professor Alan Stitt, Ph.D., CSO at Oxurion NV comments:

Related Keywords

Boston ,Massachusetts ,United States ,Leuven ,Region Flamande ,Belgium ,Jean Feyen Oxurion ,Wouter Piepers ,Sylvie Berrebi Frazer Hall ,Christopher Brinzey ,Citigate Dewe Rogerson ,Corporate Communications ,Association For Research ,Euronext Brussels ,Alan Stitt ,Karen Beets ,Jean Feyen ,Investor Relations ,Globe Newswire ,Europe ,Business ,Health ,போஸ்டன் ,மாசசூசெட்ஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,பெல்ஜியம் ,பெருநிறுவன தகவல்தொடர்புகள் ,சங்கம் க்கு ஆராய்ச்சி ,ஆலன் ஸ்டிட் ,முதலீட்டாளர் உறவுகள் ,யூரோப் ,வணிக ,ஆரோக்கியம் ,